Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▲ |
|---|---|---|---|
| 1DE4 | P61769 | HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR | HEMOCHROMATOSIS PROTEIN/BETA-2-MICROGLOBULIN/TRANSFERRIN RECEPTOR |
| 1DE4 | P02786 | HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRIN RECEPTOR | HEMOCHROMATOSIS PROTEIN/BETA-2-MICROGLOBULIN/TRANSFERRIN RECEPTOR |
| 9LYZ | P00698 | X-RAY CRYSTALLOGRAPHY OF THE BINDING OF THE BACTERIAL CELL WALL TRISACCHARIDE NAM-NAG-NAM TO LYSOZYME | HEN EGG WHITE LYSOZYME (E.C.3.2.1.17) |
| 1A7S | P20160 | ATOMIC RESOLUTION STRUCTURE OF HBP | HEPARIN BINDING PROTEIN |
| 1JMA | P57083 | CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM | HERPESVIRUS ENTRY MEDIATOR, GLYCOPROTEIN D |
| 1JMA | Q92956 | CRYSTAL STRUCTURE OF THE HERPES SIMPLEX VIRUS GLYCOPROTEIN D BOUND TO THE CELLULAR RECEPTOR HVEA/HVEM | HERPESVIRUS ENTRY MEDIATOR, GLYCOPROTEIN D |
| 1HVQ | P23472 | CRYSTAL STRUCTURES OF HEVAMINE, A PLANT DEFENCE PROTEIN WITH CHITINASE AND LYSOZYME ACTIVITY, AND ITS COMPLEX WITH AN INHIBITOR | HEVAMINE A |
| 2E2O | Q96Y14 | Crystal structure of Sulfolobus tokodaii hexokinase in complex with glucose | HEXOKINASE (E.C.2.7.1.1) |
| 2E2Q | Q96Y14 | Crystal structure of Sulfolobus tokodaii hexokinase in complex with xylose, Mg2+, and ADP | HEXOKINASE (E.C.2.7.1.1) |
| 4CCV | Q28640 | Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: Implications for the regulation of angiogenesis | HISTIDINE-RICH GLYCOPROTEIN |
| 6P65 | 6P65 | HIV Env 16055 NFL TD 2CC+ in complex with antibody 1C2 fragment antigen binding | HIV Env 16055 NFL TD 2CC+, Rabbit antibody 1C2 heavy chain fragment antigen binding, Rabbit antibody 1C2 kappa chain |
| 4R4H | 4R4H | Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120 | HIV-1 89.6P gp120, T-cell surface glycoprotein CD4, Antibody 2.2c, Light chain, Antibody 2.2c, Heavy chain |
| 4R4H | P01730 | Crystal structure of non-neutralizing, A32-like antibody 2.2c in complex with HIV-1 Env gp120 | HIV-1 89.6P gp120, T-cell surface glycoprotein CD4, Antibody 2.2c, Light chain, Antibody 2.2c, Heavy chain |
| 4YFL | Q0ED31 | Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120 | HIV-1 93TH057 gp120, 1B2530 heavy chain, 1B2530 Light chain |
| 4YFL | 4YFL | Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex with HIV-1 clade A/E 93TH057 gp120 | HIV-1 93TH057 gp120, 1B2530 heavy chain, 1B2530 Light chain |
| 4LSS | 4LSS | Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 clade A strain KER_2018_11 gp120 | HIV-1 CLADE A STRAIN KER2018_11 GP120, HEAVY CHAIN OF ANTIBODY VRC01, LIGHT CHAIN OF ANTIBODY VRC01 with N72T mutation |
| 4LSQ | 4LSQ | Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E gp120 93TH057 with LOOP D and Loop V5 from clade A strain 3415_v1_c1 | HIV-1 CLADE A/E STRAIN 93TH057 GP120 WITH LOOP D AND V5 FROM STRAIN 3415_V1_C1, HEAVY CHAIN OF ANTIBODY VRC-CH31, LIGHT CHAIN OF ANTIBODY VRC-CH31 WITH N70D MUTATION |
| 4LSR | 4LSR | Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clade A/E stran 93TH057 gp120 with LOOP D and Loop V5 from clade A strain KER_2018_11 | HIV-1 CLADE A/E STRAIN 93TH057 GP120 WITH LOOP D AND V5 FROM STRAIN ker_2018_11, HEAVY CHAIN OF ANTIBODY VRC-CH31, LIGHT CHAIN OF ANTIBODY VRC-CH31 WITH N70D UTATION |
| 4LSU | 4LSU | Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clade A/E 93TH057 gp120 | HIV-1 CLADE A/E STRAIN 93TH057 GP120, HEAVY CHAIN OF ANTIBODY VRC-PG20, LIGHT CHAIN OF ANTIBODY VRC-PG20 |
| 4LSV | 4LSV | Crystal structure of broadly and potently neutralizing antibody 3BNC117 in complex with HIV-1 clade C C1086 gp120 | HIV-1 CLADE C STRAIN C1086 GP120 coreE, HEAVY CHAIN OF ANTIBODY 3BNC117, LIGHT CHAIN OF ANTIBODY 3BNC117 |
| 4RX4 | 4RX4 | Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC134 in complex with HIV-1 clade A Q842.d12 gp120 | HIV-1 Clade A Q842.d12 gp120, 8ANC134 Heavy chain, 8ANC134 Light Chain |
| 3SE9 | 3SE9 | Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120 | HIV-1 Clade AE strain 93TH057 gp120, Heavy chain of antibody VRC-PG04, Light chain of antibody VRC-PG04 |
| 3SE8 | 3SE8 | Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120 | HIV-1 Clade AE strain 93TH057 gp120, Heavy chain of antibody VRC03, Light chain of antibody VRC03 |
| 5FUU | Q75760 | Ectodomain of cleaved wild type JR-FL EnvdCT trimer in complex with PGT151 Fab | HIV-1 ENVELOPE GLYCOPROTEIN GP160, IMMUNOGLOBULIN G PGT151 |
| 5FUU | Q6BC19 | Ectodomain of cleaved wild type JR-FL EnvdCT trimer in complex with PGT151 Fab | HIV-1 ENVELOPE GLYCOPROTEIN GP160, IMMUNOGLOBULIN G PGT151 |
| 5FUU | 5FUU | Ectodomain of cleaved wild type JR-FL EnvdCT trimer in complex with PGT151 Fab | HIV-1 ENVELOPE GLYCOPROTEIN GP160, IMMUNOGLOBULIN G PGT151 |
| 5ACO | Q2N0S6 | Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer | HIV-1 ENVELOPE GLYCOPROTEIN, PGT128 FAB |
| 5ACO | 5ACO | Cryo-EM structure of PGT128 Fab in complex with BG505 SOSIP.664 Env trimer | HIV-1 ENVELOPE GLYCOPROTEIN, PGT128 FAB |
| 6NC3 | 6NC3 | AMC011 v4.2 SOSIP Env trimer in complex with fusion peptide targeting antibody VRC34 fragment antigen binding | HIV-1 Env AMC011 v4.2 SOSIP gp120, HIV-1 Env AMC011 v4.2 SOSIP gp41, Monoclonal antibody VRC34.01 fragment antigen binding heavy chain, Monoclonal antibody VRC34.01 fragment antigen binding light chain |
| 6NF5 | 6NF5 | BG505 MD64 N332-GT5 SOSIP trimer in complex with BG18-like precursor HMP1 fragmentantigen binding and base-binding RM20A3 fragment antigen binding | HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp120, HIV-1 Env BG505 MD64 N332-GT5 SOSIP gp41, BG18-like precursor HMP1 fragment antigen binding heavy chain, V2-17 protein, base-binding RM20A3 fragment antigen binding heavy chain, base-binding RM20A3 fragment antigen binding light chain |
| 6P62 | 6P62 | HIV Env BG505 NFL TD+ in complex with antibody E70 fragment antigen binding | HIV-1 Env BG505 NFL TD+, Rabbit monoclonal antibody E70 heavy chain fragment antigen binding, Rabbit monoclonal antibody E70 kappa chain |
| 6X9T | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9T | 6X9T | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9U | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9U | 6X9U | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9V | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9V | 6X9V | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9R | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9R | 6X9R | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9S | Q2N0S6 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 6X9S | 6X9S | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
| 7KDE | Q2N0S6 | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein gp120, Ab 1485 Heavy Chain, Ab 1485 Light Chain, 8ANC195 Fab Heavy Chain, 8ANC195 Fab Light Chain |
| 7KDE | 7KDE | BG505 SOSIP.664 in complex with the V3-targeting rhesus macaque antibody 1485 and human gp120-gp41 interface antibody 8ANC195 | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein gp120, Ab 1485 Heavy Chain, Ab 1485 Light Chain, 8ANC195 Fab Heavy Chain, 8ANC195 Fab Light Chain |
| 5A8H | 5A8H | cryo-ET subtomogram averaging of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195 | HIV-1 GP120, T-CELL SURFACE GLYCOPROTEIN CD4, FAB OF BROADLY NEUTRALIZING ANTIBODY 17B, FAB OF BROADLY NEUTRALIZING ANTIBODY 8ANC195 VARIANT G52K5 |
| 5A8H | P01730 | cryo-ET subtomogram averaging of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195 | HIV-1 GP120, T-CELL SURFACE GLYCOPROTEIN CD4, FAB OF BROADLY NEUTRALIZING ANTIBODY 17B, FAB OF BROADLY NEUTRALIZING ANTIBODY 8ANC195 VARIANT G52K5 |
| 5A7X | 5A7X | negative stain EM of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195 | HIV-1 YU2 GP120, T-CELL SURFACE GLYCOPROTEIN CD4, FAB OF BROADLY NEUTRALIZING ANTIBODY 17B, FAB OF BROADLY NEUTRALIZING ANTIBODY 8ANC195 |
| 5A7X | P01730 | negative stain EM of BG505 SOSIP.664 in complex with sCD4, 17b, and 8ANC195 | HIV-1 YU2 GP120, T-CELL SURFACE GLYCOPROTEIN CD4, FAB OF BROADLY NEUTRALIZING ANTIBODY 17B, FAB OF BROADLY NEUTRALIZING ANTIBODY 8ANC195 |
| 4JZZ | 4JZZ | Crystal structure of CD4-mimetic miniprotein M48U1 in complex with HIV-1 YU2 gp120 in C2221 space group | HIV-1 YU2 gp120 glycoprotein, CD4-MIMETIC MINIPROTEIN M48U1 |
| 4K0A | 4K0A | Crystal structure of CD4-mimetic miniprotein M48U7 in complex with HIV-1 YU2 gp120 | HIV-1 YU2 gp120 glycoprotein, CD4-MIMETIC MINIPROTEIN M48U7 |
| 4RWY | 4RWY | Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 8ANC131 in complex with HIV-1 clade B YU2 gp120 | HIV-1 YU2 gp120, Antibody 8ANC131 heavy chain, Antibody 8ANC131 light chain |
